Company: PRGO
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0001585364-25-000014
Chunk: 209

Company: PERRIGO Co plc
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 209
---
116.3 107.3 Total net sales$4,373.4 $4,655.6 $4,451.6 (1)    The net sales by geography is derived from the location of the entity that sells to a third party.(2)    Includes Ireland net sales of $39.6 million, $40.8 million, and $29.3 million for the years ended December 31, 2024, December 31, 2023, and December 31, 2022, respectively.(3)    Includes revenue generated primarily in Australia and Canada during the years ended December 31, 2024 and 2023. During the year ended December 31, 2022, includes revenue generated primarily in Australia, Canada, and Mexico.

74

Perrigo Company plc - Item 8Note 2

Product CategoryThe following is a summary of our net sales by category (in millions): Year EndedDecember 31, 2024December 31, 2023December 31, 2022CSCA(1)Upper Respiratory$500.3 $561.4 $567.3 Digestive Health497.4 507.5 498.8 Nutrition449.5 563.2 524.3 Pain and Sleep-Aids345.5 397.2 412.8 Healthy Lifestyle306.8 311.4 287.9 Oral Care275.4 310.4 315.4 Skin Care220.1 240.5 237.6 Women's Health81.1 48.6 47.4 Vitamins, Minerals, and Supplements ("VMS")14.5 18.5 28.3 Other CSCA(2)3.1 3.6 6.1 Total CSCA2,693.7 2,962.3 2,925.9 CSCISkin Care410.0 372.5 334.6 Upper Respiratory282.1 299.1 268.7 Healthy Lifestyle225.8 225.7 209.7 Pain and Sleep-Aids222.2 222.9 200.2 VMS173.5 185.5 183.9 Women's Health132.8 119.7 96.1 Oral Care99.